Table 2.
Demographic data, background and neurologic complains and other symptoms
| Demographics | Age | 50 ± 11.5 |
| Female | 30 (65%) | |
| Education years | 14 ± 3.9 | |
| Comorbidities | Hyperlipidemia | 10 (22%) |
| DM | 9 (20%) | |
| Hypertension | 6 (13%) | |
| Asthma | 6 (13% | |
| Rheumatoid arthritis | 2 (4%) | |
| Factor V Leiden | 1 (2%) | |
| Familial Mediterranean fever | 1 (2%) | |
| IHD | 1 (2%) | |
| COPD | 1 (2%) | |
| Common complaints | Memory symptoms | 46 (100%) |
| Mood disturbance | 38 (84%) | |
| Dyspnea | 36 (80%) | |
| IADL impairment | 31 (67%) | |
| Cough | 30 (67%) | |
| Headache | 27 (60%) | |
| Arthralgia | 13 (29%) | |
| Hair loss | 8 (18%) | |
| Hyposmia/dysgeusia | 7 (15%) | |
| Hearing loss | 4 (9%) | |
| Disease severity | Severe cases | 10 (22%) |
| Non-severe cases | 36 (78%) | |
| Hospitalized | 15 (33%) | |
| Non-Hospitalized | 31 (67%) | |
| Lab Tests | Hemoglobin | 13.6 ± 1.4 g/dl |
| Cobalamin B12 | 396 ± 232 pg/mL | |
| Thyroid stimulating hormone (TSH) | 2 ± 0.9 mIU/L | |
| Forced expiratory flow 1st second (FEV1) | 94.2% ± 13.8% | |
| Forced vital capacity (FVC) | 96.2 ± 14.9% | |
| Diffusion capacity (DLCO) | 73.5 ± 12.2% |
IHD Ischemic Heart Disease, COPD Chronic Obstructive Pulmonary Disease, DM Diabetes Mellitus, ADL Activity of Daily Living